$130.00
BPC-157 + TB-500 + GHK-Cu + KPV
Contents: 80 mg | BPC-157 (10mg) + TB-500 (10mg) + GHK-Cu (50mg) + KPV (10mg)
Form: Lyophilized Powder
Purity: ≥ 99% USA Tested, Verified Purity (HPLC Tested)
Verification: Verifiable COA’s (Batch-Matched)
Emerging Research Evidence:
The KLOW research blend is studied in laboratory models to investigate integrated tissue restoration and inflammatory-signaling pathways. Researchers examine how the combined analytes influence collagen synthesis, microcirculation, dermal remodeling, and mucosal barrier integrity. Ongoing investigations focus on coordinated cellular signaling across connective tissue, skin, and gut-immune interfaces in controlled experimental settings.
Keep product in cool, dark place.
Sold for Research Use Only / Not FDA Regulated
Batch-verified inventory. See 3rd Party COA.
In stock
KLOW is studied in pre-clinical models as a comprehensive structural repair blueprint that coordinates multiple cellular signaling pathways at once. By combining GHK-Cu, BPC-157, TB-500, and KPV, this blend allows researchers to observe the accelerated stabilization of the cellular framework and the mapping of complex tissue-repair dynamics. The primary research benefit of this formulation is its ability to simulate full-system recovery coordination, providing high-resolution data on how structural rebuilding, signaling balance, and barrier protection intersect. These investigations focus on the positive synchronization of recovery markers and structural remodeling in laboratory environments, without reference to therapeutic outcomes or clinical efficacy.
(15-aa “Body Protection Compound” fragment)
Research Focus:
Connective tissue signaling
Cytoprotective pathway evaluation
Inflammatory-response modulation
(N-acetyl-LKKTETQ; thymosin-β4 fragment 17–23)
Research Focus:
Actin-binding and cellular migration pathways
Angiogenic signaling models
Soft-tissue structural remodeling
(Copper(II) tripeptide complex of Gly-His-Lys)
Research Focus:
Dermal matrix remodeling
Collagen-related gene signaling
Oxidative-stress response pathways
(α-MSH fragment 11–13)
Research Focus:
Anti-inflammatory signaling pathways
Epithelial barrier and mucosal integrity models
Host-defense peptide signaling
Multi-pathway tissue regeneration biology
Inflammatory pathway regulation
Structural ECM remodeling
Dermal and connective-tissue signaling
Gut-immune axis modulation
KLOW is utilized as a precision multi-pathway blueprint for studying the coordinated signaling of tissue regeneration and structural rebuilding. In laboratory models, this blend allows researchers to track how different cellular signals work together to stabilize the framework and protect the internal environment. These investigations focus on mapping the synchronized flow of repair messages—specifically how the cellular matrix and protective pathways interact—to understand the foundation of recovery, without reference to therapeutic or clinical outcomes.
Research-only note: KLOW is not FDA-approved for therapeutic use. Published effects are primarily preclinical and exploratory.
For Research Use Only — Not for Human or Veterinary Use. Not evaluated or approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. All information on this website is provided strictly for laboratory research and educational purposes. Nothing herein constitutes medical, clinical, or legal advice, nor an endorsement of non-laboratory use. Any discussion of specific peptides or potential research findings is informational only and must not be interpreted as guidance for use in or on humans or animals.
